BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alves Galvão MG, Rocha Crispino Santos MA, Alves da Cunha AJ. Amantadine and rimantadine for influenza A in children and the elderly. Cochrane Database Syst Rev 2014;:CD002745. [PMID: 25415374 DOI: 10.1002/14651858.CD002745.pub4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Y, Gammeltoft KA, Galli A, Offersgaard A, Fahnøe U, Ramirez S, Bukh J, Gottwein JM. Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro. Viruses 2021;13:2082. [PMID: 34696509 DOI: 10.3390/v13102082] [Reference Citation Analysis]
2 Santos IA, Pereira AKDS, Guevara-Vega M, de Paiva REF, Sabino-Silva R, Bergamini FRG, Corbi PP, Jardim ACG. Repurposing potential of rimantadine hydrochloride and development of a promising platinum(II)-rimantadine metallodrug for the treatment of Chikungunya virus infection. Acta Trop 2022;227:106300. [PMID: 34979144 DOI: 10.1016/j.actatropica.2021.106300] [Reference Citation Analysis]
3 Dyrka K, Miedziaszczyk M, Szałek E, Łącka K. Drugs used in viral diseases – their mechanism of action, selected adverse effects and safety during pregnancy and lactation. Postepy Hig Med Dosw 2019;73:491-507. [DOI: 10.5604/01.3001.0013.5249] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Chen KK, Minakuchi M, Wuputra K, Ku CC, Pan JB, Kuo KK, Lin YC, Saito S, Lin CS, Yokoyama KK. Redox control in the pathophysiology of influenza virus infection. BMC Microbiol 2020;20:214. [PMID: 32689931 DOI: 10.1186/s12866-020-01890-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Bugert JJ, Hucke F, Zanetta P, Bassetto M, Brancale A. Antivirals in medical biodefense. Virus Genes 2020;56:150-67. [PMID: 32076918 DOI: 10.1007/s11262-020-01737-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
6 Lehnert R, Pletz M, Reuss A, Schaberg T. Antiviral Medications in Seasonal and Pandemic Influenza. Dtsch Arztebl Int 2016;113:799-807. [PMID: 28043323 DOI: 10.3238/arztebl.2016.0799] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
7 Li P, Du R, Wang Y, Hou X, Wang L, Zhao X, Zhan P, Liu X, Rong L, Cui Q. Identification of Chebulinic Acid and Chebulagic Acid as Novel Influenza Viral Neuraminidase Inhibitors. Front Microbiol 2020;11:182. [PMID: 32256457 DOI: 10.3389/fmicb.2020.00182] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
8 Tyrrell BE, Sayce AC, Warfield KL, Miller JL, Zitzmann N. Iminosugars: Promising therapeutics for influenza infection. Crit Rev Microbiol 2017;43:521-45. [PMID: 27931136 DOI: 10.1080/1040841X.2016.1242868] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
9 Maki A, Evans R, Ghezzi P. Bad News: Analysis of the Quality of Information on Influenza Prevention Returned by Google in English and Italian. Front Immunol 2015;6:616. [PMID: 26697012 DOI: 10.3389/fimmu.2015.00616] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
10 Yuan Y, Wang RT, Xia J, Cao HJ. Interventions for preventing influenza: An overview of Cochrane systematic reviews and a Bayesian network meta-analysis. J Integr Med 2021;19:503-14. [PMID: 34544670 DOI: 10.1016/j.joim.2021.09.001] [Reference Citation Analysis]
11 Scala MC, Agamennone M, Pietrantoni A, Di Sarno V, Bertamino A, Superti F, Campiglia P, Sala M. Discovery of a Novel Tetrapeptide against Influenza A Virus: Rational Design, Synthesis, Bioactivity Evaluation and Computational Studies. Pharmaceuticals (Basel) 2021;14:959. [PMID: 34681184 DOI: 10.3390/ph14100959] [Reference Citation Analysis]
12 Ratre YK, Vishvakarma NK, Bhaskar LVKS, Verma HK. Dynamic Propagation and Impact of Pandemic Influenza A (2009 H1N1) in Children: A Detailed Review. Curr Microbiol. 2020;77:3809-3820. [PMID: 32959089 DOI: 10.1007/s00284-020-02213-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
13 Zhang Y, Wang R, He C, Zhang YF, Luo Z, Luo J, Chen S, Jin Y, Xie B, Liu Y. Amantadine-assembled nanostimulator enhances dimeric RBD antigen-elicited cross-neutralization against SARS-CoV-2 strains. Nano Today 2022;43:101393. [PMID: 35035515 DOI: 10.1016/j.nantod.2022.101393] [Reference Citation Analysis]
14 Tencheva A, Liu R, Volkova TV, Chayrov R, Mitrev Y, Štícha M, Li Y, Jiang H, Li Z, Stankova I, Perlovich GL. Synthetic analogues of memantine as neuroprotective and influenza viral inhibitors: in vitro and physicochemical studies. Amino Acids 2020;52:1559-80. [PMID: 33191465 DOI: 10.1007/s00726-020-02914-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Giampieri R, Cantini L, Giglio E, Bittoni A, Lanese A, Crocetti S, Pecci F, Copparoni C, Meletani T, Lenci E, Lupi A, Baleani MG, Berardi R. Impact of Polypharmacy for Chronic Ailments in Colon Cancer Patients: A Review Focused on Drug Repurposing. Cancers (Basel) 2020;12:E2724. [PMID: 32977434 DOI: 10.3390/cancers12102724] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]